BSE Live
Dec 11, 16:01Prev. Close
345.20
Open Price
343.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 11, 15:45Prev. Close
343.25
Open Price
341.10
Bid Price (Qty.)
347.15 (101)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Gufic Biosciences (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 22.69 | 21.94 | 16.02 | 9.02 | 11.19 | |
| Net CashFlow From Operating Activities | 47.10 | 5.21 | -4.85 | -4.13 | -4.32 | |
| Net Cash Used In Investing Activities | -42.53 | -12.99 | -8.84 | -4.69 | -0.51 | |
| Net Cash Used From Financing Activities | -4.21 | 7.71 | 14.49 | 7.41 | 4.78 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.36 | -0.08 | 0.80 | -1.41 | -0.05 | |
| Cash And Cash Equivalents Begin of Year | 3.90 | 3.74 | 2.87 | 4.28 | 6.21 | |
| Cash And Cash Equivalents End Of Year | 4.26 | 3.66 | 3.67 | 2.87 | 6.16 |
04.12.2025
Gufic Bio Consolidated September 2025 Net Sales at Rs 237.05 crore, up 16.1% Y-o-Y
13.06.2025
Gufic Bio Standalone March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
05.06.2025
Gufic Bio Consolidated March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
11.03.2025
Gufic Bio Consolidated December 2024 Net Sales at Rs 207.79 crore, up 2.98% Y-o-Y
04.12.2025
Gufic Bio Consolidated September 2025 Net Sales at Rs 237.05 crore, up 16.1% Y-o-Y
13.06.2025
Gufic Bio Standalone March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
05.06.2025
Gufic Bio Consolidated March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
11.03.2025
Gufic Bio Consolidated December 2024 Net Sales at Rs 207.79 crore, up 2.98% Y-o-Y